← Leaderboards
Erik Gentalen
Intabio, Inc.
$2,321,326
Attributed
$2,321,326
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2018–19$2M$1.5M$1M$500K$0
'18
'19
Funding mix
By agency
NIH$2,321,326 · 1
By mechanism
R44$2,321,326 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Advanced Development”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$378,174,673
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Joel A Lipkin · Four Points Technology, Llc$181,896,915
- Kimberly Smith · Ppd Development Lp$115,671,664
Research focus
Advanced DevelopmentAffectBackBaseBiological ProductsBlood CapillariesCellsChargeChip-On-ChipChromatographyCommercializationComplexComputer SoftwareCostData DisplayDesignDetectionDevice Or Instrument DevelopmentDrug DevelopmentDrug QualityEffective TherapyElectrodesGenerationsAbsorption